Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $3.02 USD
Change Today -0.06 / -1.95%
Volume 241.7K
BTX On Other Exchanges
Symbol
Exchange
BTX is not on other exchanges.
As of 8:04 PM 08/31/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Robert W. Peabody CPA

Chief Financial Officer and Senior Vice President,BioTime, Inc.
AgeTotal Calculated CompensationThis person is connected to 17 board members in 3 different organizations across 7 different industries.

See Board Relationships
61$788,316
As of Fiscal Year 2014

Background*

Mr. Robert W. Peabody, CPA, has been the Chief Financial Officer of Asterias Biotherapeutics, Inc. since June 2013. Mr. Peabody serves as the Chief Operating Officer of ES Cell International Pte Ltd. He has been a Senior Vice President of BioTime, Inc. since October 2007 and as its Chief Financial Officer since May 10, 2013. He serves as an Advisor at LifeMap Sciences, Inc. He served as the Chief Operating Officer of BioTime, Inc. since October 2007. He served as the ...

Read Full Background

Corporate Headquarters*

1301 Harbor Bay Parkway
Alameda, California 94502

United States

Phone: 510-521-3390
Fax: 510-521-3389

Board Members Memberships*

Chief Operating Officer and Director
Executive Officer and Director
2014-Present
Chief Financial Officer and Director

Education*

BBA
University of Michigan

Other Affiliations*

Annual Compensation*

Salary$430,135
Bonus$107,500
Total Annual Compensation$537,635

Stock Options*

All Other Compensation$13,000
Exercisable Options68,750
Unexercisable Options131,250
Total Number of Options200,000

Total Compensation*

Total Annual Cash Compensation$550,635
Total Short Term Compensation$537,635
Other Long Term Compensation$13,000
Total Calculated Compensation$788,316
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
BTX:US $3.02 USD -0.06

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Olav Hellebo Chief Executive Officer and Director
ReNeuron Group plc
225.0K GBP
Paul K. Wotton Ph.D.Chief Executive Officer, President and Director
Ocata Therapeutics, Inc.
$243.3K
I. Richard Garr J.D.Co-Founder, Chief Executive Officer, President, General Counsel and Director
Neuralstem, Inc.
$651.2K
Yokoyama Chikafumi Ph.D.Chief Executive Officer, President and Representative Director
ReproCELL, Inc.
--
Keith Murphy Chairman, Chief Executive Officer, President, Member of Audit Committee and Member of Science & Technology Committee
Organovo Holdings, Inc.
$469.9K
Compensation as of Fiscal Year 2015.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact BIOTIME INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.